Clinical Trial Update: Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates an ongoing Phase 1/Phase 2 study of Olvi-Vec in combination with platinum-based chemotherapy and etoposide for extensive-stage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Etoposide (Etoposide)
• Olvi-Vec
• Platinum-based chemotherapy (cisplatin or carboplatin)

Snippet

Sponsor: Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. | Conditions: SCLC, Extensive Stage | Phase 1, Phase 2 | Status: RECRUITING